- AdventHealth Research Institute
A new systematic review of clinical trials has found that no single dietary pattern consistently improves blood sugar control or weight management in youth and adults living with type 1 diabetes. The findings highlight the urgent need for more rigorous research into precision nutrition strategies tailored to individual patient needs.
Researchers analyzed 12 studies comprised of 11 clinical trials conducted between 2011 and 2024, involving 668 youth and adults with type 1 diabetes. The studies compared various diet patterns including Mediterranean, low and moderate carbohydrate, low fat, and generally healthful diets. Outcomes that were pooled in meta-analyses included glycated hemoglobin (HbA1c) and weight. Results showed:
No consistent benefit of any specific diet pattern in randomized trials.
Low-carbohydrate diets in single-arm studies suggested improvements in HbA1c (−0.63% [95% CI, −0.99 to −0.27]), but evidence quality was graded as being very low.
Meta-analyzed results suggested the possibility of variation in response to diet patterns between individuals, based upon wide pooled confidence intervals.
However, dedicated studies are needed to evaluate whether true heterogeneity in response to diet patterns exists, which would indicate the need to tailor diets to individual characteristics in “precision nutrition” paradigms.
Despite these findings, most studies did not stratify results by participant characteristics such as age, sex, or baseline metabolic profile — limiting insights into who might benefit most from specific dietary approaches.
The study underscores the importance of determining whether diet approaches that account for interindividual differences in metabolism, lifestyle, and treatment goals are more effective than one-size-fits-all dietary recommendations.
Conclusion
High-quality randomized trials are needed to determine whether tailored nutrition recommendations will help to optimize glycemia and weight management in people with type 1 diabetes. Until strategies for determining the optimal diet for a given individual emerge, current recommendations to individualize diet counseling to individual and cultural preferences should continue to be followed.
Recent News
How Diet Shapes Gut Microbes and Energy Absorption
What we eat has a big impact on the bacteria living in our gut, which in turn affects how our bodies use energy—something that plays a major role in the development and treatment of obesity.
AdventHealth Neuroscience Institute Launches NIH-Funded THRIVE Trial
AdventHealth Neuroscience Institute has launched THRIVE, an NIH-funded clinical trial led by Lauren Oberlin, PhD, geriatric neuropsychologist and neuroscience researcher.
AdventHealth Tampa Enrolls First Patient in the Tectonic CAD IVL Trial
On September 19, 2025, AdventHealth Tampa successfully enrolled its first patient in the Tectonic CAD Intravascular Lithotripsy (IVL) Trial, led by Dr. Mahmaljy and his team.
MANIFEST US Study Presented as a Late-Breaking Clinical Trial at AHA
The cardiovascular team is excited to highlight the MANIFEST US study, which was presented on November 10th as a Late-Breaking Clinical Trial at the American Heart Association (AHA) Scientific...
Nourishing Your Gut: Dr. Karen Corbin on the Power of Fiber
Dr. Karen Corbin, associate investigator at the AdventHealth Translational Research Institute for Metabolism and Diabetes in Orlando, emphasizes the essential role of diet in maintaining a healthy gut...
Southeast Region – Redmond Campus: AdventHealth Recognized as Top Enroller Nationally for the CARVTOP-ICD Trial
AdventHealth Research Institute (AHRI) is proud to announce that the Southeast Region’s Redmond Campus has been recognized as the top enrolling site nationally for the CARVTOP-ICD trial.
Stiff Arteries Linked to Early Memory Decline: New Findings by Dr. Amani Norling
Amani Norling, PhD a post-doctoral fellow at the AdventHealth Neuroscience institute, has published a notable paper titled “Arterial stiffness moderates the link between NfL and cognition: The IGNITE...
First BrioVAD Implant Successfully Completed
On September 24, the Transplant team successfully implanted the first BrioVAD device at AdventHealth, a major milestone in the ongoing INNOVATE 2254936 Vidic trial.
Advancing T1D Science: New TRI Publications
Researchers at the AdventHealth Translational Research Institute continue to drive meaningful progress in Type 1 diabetes—work that is being recognized not just in Central Florida, but throughout the...
The T1D Daily Reset: Small Habits With Big Impact
As we head into 2026, many people living with Type 1 diabetes are looking for ways to reset their routines and start the year feeling more balanced and in control.
The Next Frontier: Preventing Type 1 Diabetes Before It Starts
Recent research led by AdventHealth’s Translational Research Institute and others reveals that Type 1 diabetes develops gradually and can now be detected early through blood tests, opening the door to...
Advancing Heart Care: A New Chapter with the BrioVAD Study
The AdventHealth Research team recently completed Core Training for the INNOVATE 2254936 Vidic trial, bringing this novel device to AdventHealth.